RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti's Q3 loss is narrower than estimates, but revenues decline as government contract delays hit sales and lower the gross margin.
AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down
AMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.
Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
INGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.
Wall Street Analysts Think West Pharmaceutical ( WST ) Could Surge 25.41%: Read This Before Placing a Bet
The mean of analysts' price targets for West Pharmaceutical (WST) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Wall Street Analysts Think West Pharmaceutical ( WST ) Could Surge 25.41%: Read This Before Placing a Bet
The mean of analysts' price targets for West Pharmaceutical (WST) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday
The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance.
Here's Why You Should Add OPKO Health Stock to Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand - West Pharmaceutical Servs ( NYSE:WST )
West Pharmaceutical Services, Inc. ( NYSE:WST ) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company's third-quarter 2025 earnings surpassed analyst estimates. West Pharmaceutical reported adjusted earnings of $1.96 per share, beating the consensus ...
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday - Alcoa ( NYSE:AA ) , CACI International ( NYSE:CACI )
U.S. stocks were mixed, with the Dow Jones index falling around 0.1% on Thursday. Shares of Las Vegas Sands Corp. ( NYSE:LVS ) surged 11.8% to $56.64 after the company reported third-quarter EPS and sales above expectations, raised its dividend and added $2 billion to its stock buyback program.
West Pharmaceutical Services ( WST ) Tops Q3 Earnings and Revenue Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of +17.37% and +2.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing
AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.
WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?
West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.
Reasons to Add HealthEquity Stock to Your Portfolio for Now
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation
Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
Ecolab Brings Direct-to-Chip Cooling Monitoring to Southeast Asia
ECL debuts its 3D TRASAR direct-to-chip cooling monitoring in Singapore, boosting efficiency and sustainability in data centers.
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - West Pharmaceutical Servs ( NYSE:WST )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In West Pharmaceuticals ( WST ) To Contact Him Directly To Discuss Their Options NEW YORK, Oct. 08, 2025 ( GLOBE NEWSWIRE ) --
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
ECL's robust product lineup, innovation-driven growth and strong Q2 results underscore its long-term potential despite macroeconomic headwinds.
Nyxoah Shares Rise on First U.S. Commercial Use of Genio System
NYXH's first U.S. commercial use of its Genio system signals strong physician demand and sets the stage for broad adoption in sleep apnea care.
CAH Expands Distribution Network With Indianapolis Facility
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Sight Sciences highlights a new meta-analysis showing OMNI delivers lasting safety, efficacy and economic value in glaucoma treatment.
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains.
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
